NEW YORK (GenomeWeb News) – RayBiotech today announced a deal with Innopsys to co-market each other's technologies.
Under the agreement, RayBiotech and Innopsys will co-promote RayBiotech's G-Series and Quantibody series of antibody arrays and array testing services with Innopsys' Innoscan laser microarray scanning platforms.
The partnership is the first of a series of deals that RayBiotech plans to pursue in 2012 in order to accelerate adoption of the firm's products and services, President, COO, and Co-founder Rani Huang said. In addition to deals with industry players, RayBiotech hopes to partner with academic and government institutions, he added.
Innopsys CEO Stephane Le Brun said in a statement that the company sees proteomics as a high-growth area. "[T]hus we view a partnership with RayBiotech as a solid reinforcement to our already growing presence in this sector," he said.
Financial and other terms of the deal were not disclosed.
RayBiotech, based in Norcross, Ga., develops antibody and protein array technologies. Innopsys is based in Carbonne, France and develops microarray scanners and associated software.